Critic at Large

» funding, science publishing, opinion and cancer

Most Recent

image: Opinion: Understanding and Coping With Rising Publication Costs

Opinion: Understanding and Coping With Rising Publication Costs

By M. Bishr Omary and Theodore S. Lawrence | September 1, 2017

As article processing charges top $5,000 at some research journals, authors and institutions have means of negotiating better deals or finding less expensive options.

0 Comments

image: Opinion: Why I Published in a Predatory Journal

Opinion: Why I Published in a Predatory Journal

By John H. McCool | April 6, 2017

Our totally bogus case report swiftly passed muster, with only minor revisions requested.

12 Comments

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

image: Pet Scans

Pet Scans

By Timothy M. Fan, Amy K. LeBlanc, and Nicola Mason | April 1, 2016

Studying tumor development and treatment in dogs and cats, in parallel with research on rodents and humans, could improve the successful translation of new cancer drugs.

0 Comments

image: Control ALT, Delete Cancer

Control ALT, Delete Cancer

By Haroldo Silva, David Halvorsen, and Jeremy D. Henson | April 1, 2015

Treating cancer by shutting down the alternative lengthening of telomeres (ALT) pathway

1 Comment

image: The Challenges of Precision

The Challenges of Precision

By Adam Marcus | April 1, 2015

Researchers face roadblocks to treating an individual patient’s cancer as a unique disease.

1 Comment

image: Fighting Cancer with Nanomedicine

Fighting Cancer with Nanomedicine

By Dean Ho | April 1, 2014

Nanotechnology-based therapeutics will revolutionize cancer treatment.

2 Comments

image: Defending Against Plagiarism

Defending Against Plagiarism

By Jonathan Bailey | June 1, 2013

Publishers need to be proactive about detecting and deterring copied text.

5 Comments

image: Researchers, Hire Hackers

Researchers, Hire Hackers

By Zeke Nierenberg and Martina Steurer-Muller | May 1, 2013

Clinical researchers need programming support to streamline their work, minimize error in the data, and find new trends that can point to better treatments.

0 Comments

image: Cancer Clinical Trials of Tomorrow

Cancer Clinical Trials of Tomorrow

By Tomasz M. Beer | April 1, 2013

Advances in genomics and cancer biology will alter the design of human cancer studies.

0 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. RNA Moves a Memory From One Snail to Another
  3. Could a Dose of Sunshine Make You Smarter?
  4. Sweden Cancels Agreement With Elsevier Over Open Access